[{"Assets_0_Q3_USD":212321000.0,"CommonStockSharesOutstanding_0_Q3_shares":58253140.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-49893000.0,"NetIncomeLoss_1_Q3_USD":-12862000.0,"NetIncomeLoss_3_Q3_USD":-39961000.0,"StockholdersEquity_0_Q3_USD":61862000.0,"Ticker":"CCXI","CIK":"1340652","name":"CHEMOCENTRYX, INC.","OfficialName":"ChemoCentryx Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1508212562.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191104"}]